NCT05908825View on ClinicalTrials.gov

Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 22, 2023

Primary Completion Date

November 16, 2023

Study Completion Date

January 26, 2024

Conditions
Photodamaged Skin
Interventions
DRUG

Vitamin C with AHA Exfoliative Serum

Catalyst is a novel skincare product comprised of low concentrations of multiple hydroxy acids and will be randomly assigned as Product A or Product B to be applied to one side of the face.

DRUG

Placebo serum

Placebo serum will be randomly assigned as Product A or Product B to be applied to one side of the face.

Trial Locations (1)

78660

Austin Institute for Clinical Research, Inc., Pflugerville

Sponsors
All Listed Sponsors
collaborator

SkinCeuticals

UNKNOWN

lead

Austin Institute for Clinical Research

NETWORK